Posted on 6/26/18
Health Dialog Extends Agreement with Harvard Health Publishing
BOSTON--(BUSINESS WIRE)--Health Dialog, a leading provider of integrated population health management solutions for health plans, risk-bearing providers and self-insured employers, has extended its 2014 agreement with . . .
Posted on 6/26/18
Agios and CStone Pharmaceuticals Announce Exclusive Collaboration
CAMBRIDGE, Mass. and SUZHOU, China, June 26, 2018 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of cellular metabolism to treat cancer . . .
Posted on 6/26/18
WEGO Health Announces Open Nominations for the WEGO Health Awards
BOSTON, June 26, 2018 (GLOBE NEWSWIRE) -- WEGO Health, the world’s largest network of patient leaders, today announced that nominations are now open for its annual . . .
Posted on 6/26/18
Peak Physical Therapy & Sports Performance Announces Rose Wan Zaid, DPT, in Quincy location
Peak Physical Therapy & Sports Performance, a South Shore practice specializing in unique programs
Posted on 6/26/18
National Alliance of Healthcare Purchaser Coalitions and Remedy Partners Collaborate
The National Alliance of Healthcare Purchaser Coalitions (National Alliance), a nonprofit network of business coalitions representing more than 12,000 purchasers and 45 million Americans, spending more . . .
Posted on 6/26/18
Arcus Biosciences and Infinity Pharmaceuticals Announce Clinical Collaboration
Arcus Biosciences, Inc. (NYSE: RCUS), a clinical-stage biopharmaceutical company focused on creating innovative cancer immunotherapies, and Infinity Pharmaceuticals, Inc. (NASDAQ: INFI), a clinical-stage biopharmaceutical company developing . . .
Posted on 6/26/18
Skyhawk Therapeutics Announces Strategic Collaboration with Celgene
Skyhawk Therapeutics, Inc., today announced a global strategic collaboration with a Celgene Corporation affiliate to discover, develop and commercialize innovative small molecule treatment options for patients with . . .
Posted on 6/26/18
Cardurion Pharmaceuticals Announces Formation of Scientific and Clinical Advisory Board
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cardurion Pharmaceuticals, a biotechnology company focused on the development of novel, next-generation therapeutics for the treatment of cardiovascular diseases, today announced that it has . . .
Posted on 6/26/18
Zafgen: 3 Key Takeaways From ADA Abstracts
Zafgen (ZFGN) released three abstracts at the American Diabetes Association conference. Amongst them included full results in a phase 2 proof-of-concept trial assessing ZGN-1061 in uncontrolled . . .
Posted on 6/25/18
InVivo Therapeutics Closes $15.2 Million Public Offering
CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) today announced the closing of its public offering of 388,403 shares of its common stock, together with warrants . . .
Posted on 6/25/18
Magenta Therapeutics Closes IPO
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Magenta Therapeutics, Inc. (NASDAQ: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of bone marrow transplant to more patients, . . .
Posted on 6/25/18
AVROBIO Closes IPO and Full Exercise of Underwriters' Overallotment Option
CAMBRIDGE, Mass., June 25, 2018 (GLOBE NEWSWIRE) -- AVROBIO, Inc. (NASDAQ:AVRO), a Phase 2 clinical stage gene therapy company focused on developing potentially curative ex vivo . . .
Posted on 6/25/18
Rhythm Pharmaceuticals Announces Closing of Public Offering
BOSTON, June 25, 2018 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a biopharmaceutical company focused on the development and commercialization of therapeutics for the treatment of . . .
Posted on 6/25/18
EyePoint Pharmaceuticals Announces Stockholder Approval of Second Tranche of Capital Financing
WATERTOWN, Mass., June 25, 2018 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, today announced . . .
Posted on 6/25/18
Akero Therapeutics Closes $65 Million Series A
Akero Therapeutics, Inc., a biotechnology company focused on transforming the treatment of non-alcoholic steatohepatitis (NASH) and other serious metabolic diseases
Posted on 6/25/18
Biogen: High Competitive Threats, But A Promising Pipeline
Biogen Inc. (BIIB) is a global biotechnology giant which has a history of creating good shareholder value through many successful drug launches. The management is recently . . .
Posted on 6/25/18
EverQuote Proposes Terms For $75 Million IPO
Quick TakeEverQuote (EVER) intends to sell 4.7 million shares at a midpoint price of $16.00 per share for gross proceeds of $91.6 million from a U.S. . . .
Posted on 6/24/18
Joslin Diabetes Center, The American Journal of Managed Care® Collaborate to Publish Clinical Guidelines
CRANBURY, N.J. & BOSTON--(BUSINESS WIRE)--The American Journal of Managed Care®has published core clinical guidelines from Joslin Diabetes Center, the world-renowned center for research, treatment, and education . . .
Posted on 6/24/18
Cerveau Technologies Signs Research Agreement with Kobe City Hospital Organisation, Japan
BOSTON--(BUSINESS WIRE)--Cerveau Technologies Inc. today announced an agreement with the Kobe City Hospital Organisation in Japan to support multiple projects over the next several years. These . . .
Posted on 6/24/18
Catabasis Pharmaceuticals Closes $42M Underwritten Public Offering
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, today announced the closing of its previously announced underwritten public offering of an aggregate of 42,000,000 . . .
Posted on 6/24/18
Nuance Ranked on Healthcare Informatics 100 for Tenth Consecutive Year
BURLINGTON, Mass., June 22, 2018 (GLOBE NEWSWIRE) -- Nuance Communications, Inc., today announced that it has been ranked #17 on the 2018 Healthcare Informatics 100, a . . .
Posted on 6/24/18
Mustang Bio Announces Opening of CAR T Cell Therapy Manufacturing Facility in Worcester, Mass.
NEW YORK, June 22, 2018 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (NASDAQ:MBIO), a Fortress Biotech (NASDAQ:FBIO) Company focused on the development of novel immunotherapies based on . . .
Posted on 6/22/18
Qstream Awarded €30,000 Prize in the Ascensia Diabetes Challenge
Qstream Microlearning Solution Proven to Help Control Glucose Levels In Patients with Type 2 DiabetesQstream, makers of software that uses science, data, and mobile technology to . . .
Posted on 6/22/18
BJ's Wholesale Club Readies Plans For $600 Million IPO
Quick TakeBJ’s Wholesale Club (BJ) intends to raise $600 million in an IPO from the sale of its common stock, according to a recent regulatory filing.The . . .
Posted on 6/22/18
Neon Therapeutics Firms Its Plan For $100 Million IPO
Quick TakeNeon Therapeutics (NTGN) intends to sell 6.25 million shares for gross proceeds of $100 million from a U.S. IPO, according to an S-1/A registration statement.The . . .

